Viral Vector GMP Manufacturing
Bringing 30 Years of Clinical & Commercial Manufacturing Experience to the Rapidly Growing Cell and Gene Therapy Market
Invested $75 Million into the future of Cell & Gene Therapy
We've expanded our CDMO service offering into the rapidly growing cell and gene therapy market.
The company constructed a world-class, purpose-built 53,000 sq. ft. viral vector development and CGMP manufacturing facility in Costa Mesa, CA.
Production Train A
Suspension Culture
-
500L Single-Use Bioreactor
Large Scale Production
-
Capable of up to 3,000L Single-Use Bioreactor and Fixed-Bed Bioreactors
Production Train B
Master & Working Cell Banking
Suspension Culture
-
50 & 500L Platform Single-Use Bioreactors
Adherent Culture
-
Capable of up to 40CS10s or 20 HS36s Batch Sizes
-
Platform ÄKTA Chromatography Skids & TFF Systems
Fill/Finish
- Supporting Clinical & Commercial Programs
- Capacity up to 2,000L Vials per Session
- Capable Filling a Variety of Vials Ranging from 2R to 50R
Purpose-Built to Reduce Process Risk
Dedicated HVAC Supply Per Suite
– Grade C Classification For Processing Suites
– Grade B Classification For Cell Banking Suite
iHP In-Suite Decontamination
SteraMist Ionized Hyrdrogen Peroxide System
– Integrated iHP System in the Viral+ Suites
– Supports Multi-Product Manufacturing
– Fully Automated – Short Cycle Time – 6 Log Kill
Additional Process Controls
– Spatial Segregation for Viral +/- Suites
– Unidirectional Flow For Viral + Suites
